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Abstract
Background: A project aimed at studying the frequency of dementia and depression in the
catchment area of the Health Centre of Chrissoupolis (HCCh), Northern Greece, was carried out.
This paper reports the association between AD and anemia among the elderly participants in this
Greek study.
Methods: Eligible participants were people 65 years or over who were (a) living in the Elderly
People's Home (all 48 subjects included); (b) visiting the Open Center for Elderly People during a
20 workday period (75 subjects) and (c) visiting the HCCh for routine medical care. The Mini
Mental State Examination (MMSE) was used in assessing the cognitive capacity of the participants.
Blood was drawn for serum hematocrit, vitamin B12 and folate determination.
Results: The prevalence proportions of possible cognitive impairment among anemic and non-
anemic males were 55.6% and 34.4%, respectively (X2 = 5.8, d.f. = 1, p = 0.016). The corresponding
proportions in females were 47.5% and 40.1 % (X2 = 1.1, d.f. = 1, p = 0.305). Using logistic
regression analysis, age-group (≥  80 yrs), type of Institute, vitamin B12 and anemia had significant
independent associations with possible cognitive impairment.
Conclusions: Anemia is a frequent finding in elderly and it may be a risk factor for dementia, but
the extent of the associated deterioration of cognitive impairment or the relation with AD is not
known. GPs should be aware of this coexistence and recommend for screening, assaying and
treating elderly people.
Background
Alzheimer's disease (AD) and other neurodegenerative
diseases affect large parts of the population worldwide
and they constitute a serious public health problem for
the aging European population [1–4]. General Practi-
tioners seem to be able to diagnose early cognitive im-
pairments, after training, among their elderly patients
[5,6]. Identifying reversible and avoidable cognitive im-
pairments seems to be also a challenge for future General
Practitioners (GPs). There are many controversies re-
garding various associated factors, which can affect the
incidence and progress of Alzheimer's disease (AD) [7,8].
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Among these factors, vitamin B12 deficiency and folate
status deterioration have been extensively discussed. Al-
though some studies reported that anemia might be a
risk factor for AD in the elderly [9–12] this subject is still
debated in the literature.
A project with the aim of studying the frequency of de-
mentia and depression among the elderly people in the
catchment area of the Chrisoupolis Health Center
(HCCh) in Northern Greece has been carried out during
the past few years. A high prevalence of cognitive impair-
ment has recently been reported in this area [13]. Thus,
it was interesting to study and discuss the laboratory
findings of the eligible subjects together with their men-
tal status ability. This paper reports the association be-
tween cognitive impairment and anemia among the
elderly participants in this Greek study.
Patients and Methods
Setting
This cross-sectional study was carried out at the catch-
ment area of the (HCCh) in Northern Greece, which com-
prises 22,000 inhabitants.
Participants
Eligible participants were people 65 years or over who
were (a) living in the Elderly People's Home (all 48 sub-
jects included); (b) visiting the Open Center for Elderly
People during a 20 workday period (75 subjects) and (c)
visiting the HCCh for routine medical care. The latter
group comprised of 413 subjects, which were randomly
selected among the elderly people visiting one of the two
outpatient clinics of the health center for the same period
of time. Thus the total number of participants was 536,
245 males and 291 females. Baseline data of the studied
population were presented in Table 1.
The study has been approved by the Scientific and Ethi-
cal Committee of the General Hospital of Kavala, Greece.
Tests
The Greek validated version of Mini Mental State Exam-
ination test (MMSE) was used [14]. For diagnostic clas-
sification of cognitive and mood disorders the criteria of
ICD-10 were applied [15]. Any subject with an MMSE
score of 24 or less was included in the possible cognitive
impairment group for analyses.
Blood (10 cc) was drawn for mean hematocrit (HCT), vi-
tamin B12 (Vit.B12) and serum folate concentrations and
was assayed in the lab of the HCCh. HCT was defined
with microHt method. Normal values were considered
when HCT was ≥  38% for males and ≥  36% for females.
Vit.B12 was defined with the Elisa method in the micro
Merieux analyzer. Normal values for Vit.B12 were con-
sidered those higher or equal to 145 pg/mL. Folate was
determined with ICIA method (Ion Capture Imune As-
say), in Imx automatic analyzer. Normal values for folate
were considered those higher or equal to 1.8 ng/mL.
Quality control is applied at this lab on a regular basis.
Table 1: Demographic and backgrounds characteristics of the studied population
Variable Elderly Open Chrissoupolis
People's Centre for Health Total
Home Elderly Centre
People
N (%) N (%) N (%) N
Age
65–74 years - 73 (27.1) 196 (72.9) 269
75–84 32 (17.1) 2 (1.1) 153 (81.8) 187
85+ 16 (20.0) - 64 (80.0) 80
Total 48 (9.0) 75 (14.0) 413 (77.1) 536
Sex
Males 19 (7.75) 72 (29.4) 154 (62.9) 245
Females 29 (10.0) 28 (9.6) 234 (80.5) 291
Marital status
Married - 71 (18.0) 324 (82.0) 395
Widowed 48 (34.04) 4 (2.8) 89 (63.1) 141
Education level
<6 years education 17 (13.4) 9 (7.1) 101 (79.5) 127
6 years education 11 (3.5) 32 (10.2) 270 (86.3) 313
6–12 years education 20 (20.8) 34 (35.4) 42 (43.7) 96BMC Family Practice 2001, 2:5 http://www.biomedcentral.com/1471-2296/2/5
Statistical analysis
All statistical analyses were carried out using SPSS for
Windows (Release 10.0). The associations between cate-
gorical variables, such as different subject groups and
prevalence of disorders, were tested by means of Pear-
son's chi square-test or Fisher's test where was appropri-
ate. To show the strength of the association, p-values are
shown in the text [16]. Comparisons of mean values be-
tween groups were made by Student's t-test or analysis of
variance. The independent influence of all potential fac-
tors in identifying the presence of cognitive impairment
was studied by means of unconditional logistic regres-
sion analysis [17].
Results
Anemia and cognitive impairment
Ninety-five (17.7%) out of the 536 participants were
found to be anemic. Of those, 47 scored higher than 24 in
the MMSE and 48 lower or equal to 24 (possibly cogni-
tive impairment) (Table 2). The association between
anemia and possible cognitive impairment was statisti-
cally significant (X2 = 5.6, d.f. = 1, p = 0.018). A separate
analysis by gender revealed that this association was true
only for males and not for females. In fact, in males the
prevalence proportions of possible cognitive impairment
among anemic and non-anemic subjects were 55.6% and
34.4%, respectively (X2 = 5.8, d.f. = 1, p = 0.016). The
corresponding proportions in females were 47.5% and
40.1% (X2 = 1.1, d.f. = 1, p = 0.305).
Vitamin B12 and cognitive impairment
The analysis of blood sample of the participants indicat-
ed an abnormal value of Vit.B12 in 56 (10.4%) subjects.
Of those, 25 subjects scored as normal in the cognitive
test and 31 were assessed as possibly cognitive impaired.
The prevalence proportions of possible cognitive impair-
ment among male participants with normal and abnor-
mal value of Vit.B12 were significantly different, 34.8%
and 62.5%, respectively (X2= 7.1, d.f. = 1, p = 0.008). The
corresponding proportions in females were not signifi-
cantly different, 40.5% and 50.0% (X2 1.0, d.f. = 1, p =
0.306).
Folate and cognitive impairment
Fifteen (2.7%) subjects (7 with a MMSE lower or equal to
24) were found to have an abnormal value of folic acid.
The prevalence proportions of possible cognitive impair-
ment among participants with normal or abnormal value
of folic acid were 39.5% and 46.7%, respectively. The as-
sociation between folic acid and possible cognitive im-
pairment was not significant (X2 = 0.3, d.f. = 1, p =
0.578).
Differences among the three institutions
A two-way analysis of variance, by MMSE classification
and institution, revealed significant differences between
the three institutions in HCT and folate (F = 4.2, d.f. = 2
and 530, p = 0.016 and F = 4.9, d.f. = 2 and 530, p =
0.008, respectively), and marked, but not significant dif-
ferences in Vit.B12 (F = 2.7, d.f. = 2 and 530, p = 0.068).
The results depicted in Table 3, show that subjects living
in the Old People's Home (OPH), had the lowest value of
HCT and Vit.B12, while those participating in the Open
Centre for the Elderly people (OCE) had the lowest value
in folate. There were similar results with respect to dif-
ferences between the two MMSE categories: participants
with possible cognitive impairment had lower values in
HCT, Vit.B12 and folate, than those with normal MMSE
score. The results in Table 3, show that the above results
for the MMSE categories were not consistent across all
three institutions, in particular those for Vit.B12 and
folate, where a reverse difference was observed in sub-
jects from the OPH. This MMSE classification by institu-
tion interaction was significant only for folate (F = 9.1,
d.f. = 2 and 530, p < 0.001).
Table 2: HCT, Vit.B12 and Folate and cognitive capacity (number 
of people and prevalence proportions)
MMSE > 24 MMSE ≤  24 Total
N  ( % )N  ( % )N  ( % )
HCT
Normal*
Male 137 (65.6) 72 (34.4) 209 (100)
Female 139 (59.9) 93 (40.1) 232 (100)
Total 276 (62.6) 165 (37.4) 441 (100)
Abnormal
Male 16 (44.4) 20 (55.6) 36 (100)
Female 31 (52.5) 28 (47.5) 59 (100)
Total 47 (49.5) 48 (50.5) 95 (100)
Vit.B12
Normal
Male 144 (65.2) 77 (34.8) 221 (100)
Female 154 (59.5) 105 (40.5) 259 (100)
Total 298 (62.1) 182 (37.9) 480 (100)
Abnormal
Male 9 (37.5) 15 (62.5) 24 (100)
Female 16 (50) 16 (50) 32 (100)
Total 25 (44.6) 31 (55.4) 56 (100)
Folate
Normal
Male 149 (62.3) 90 (37.7) 239 (100)
Female 166 (58.9) 116 (41.1) 282 (100)
Total 315 (60.3) 206 (39.5) 521 (100)
Abnormal
Male 4 (66.7) 2 (33.3) 6 (100)
Female 4 (44.4) 5 (55.6) 9 (100)
Total 8 (53.3) 7 (46.7) 15 (100)
* Normal value of HCT ≥  38% in male and >36 in femalesBMC Family Practice 2001, 2:5 http://www.biomedcentral.com/1471-2296/2/5
Logistic regression analysis
The results of the logistic regression analysis (backward,
unconditional maximum likelihood) are illustrated in
Table 4. Age-group (≥  80 yrs), type of institution, ane-
mia, Vit.B12 and folate concentrations had marked or sig-
nificant independent influences on the presence of
cognitive impairment, as indicated by MMSE score less
than the cutoff point of ≤  24. Table 4, shows also the odds
– ratios and 95% Cl for each of the above factors; it can
be seen that the risk of cognitive impairment (as meas-
ured by the odds-ratio) for age greater than 80 years,
OPH residence and abnormal value of HCT, Vit.B12 is
significantly higher than one.
Discussion
It is widely accepted that anemia is a common health
problem among elderly people, and cobalamin deficien-
cy increases with advancing age. Although there are sev-
eral studies which report an association between
cobalamin deficiency and cognitive impairment [18–21],
more studies are required to determine whether there is
a specific profile of cognitive impairments typical of
Vit.B12 deficiency. It is also widely accepted that cobala-
min deficiency may result in a variety of atypical symp-
toms and hematological changes typical of megaloblastic
anemia are frequently absent in the majority of patients
with mental disorders [22].
Our study indicated an association between cognitive
impairment and anemia, but causation cannot be as-
Table 3: Mean values (and standard deviations) of HCT, Vit.B12 and Folate in different places
Variable HCCh OCE OPH Total
M.A.(SD) M.A.(SD) M.A.(SD) M.A.(SD)
Hct (%)
MMSE > 24 40.1 (3.3) 40.1 (3.6) 39.5(3.7) 40.1 (3.3)
MMSE ≤  24 39.6 (4.7) 36.5 (6.9) 37.9 (4.3) 39.1 (4.8)
Total 39.9(3.8) 39.5 (4.5) 38.2 (4.2) 39.7 (4)
Vit.B12 (pg/mL)
MMSE > 24 463.5 (197.6) 465.0(261.9) 377.2 (207.6) 460.9(211.6)
MMSE ≤  24 438.3 (203.7) 330.9 (242.2) 434.3 (294.9) 431.1 (224.6)
Total 453.6 (200.2) 441.7(262.1) 421.2(276.3) 449 (217.1)
Folate (ng/mL)
MMSE > 24 9.3 (3.3) 11.3(5.6) 8.5 (7.8) 9.6(4.1)
MMSE ≤  24 8.0 (3.7) 7.9 (5.9) 13.4(8.5) 8.9 (5.4)
Total 8.8 (3.5) 10.7(5.8) 12.3(8.5) 9.4 (4.7)
Table 4: Results of the unconditional regression analysis
Variable B SE P-value Odds ratio 95% CI
Agea
Ageb 0.360 0.250 0.150 1.4 0.9–2.3
Agec 1.123 0.256 0.001 3.1 1.9–5.1
Place
Group
Groupd -0.854 0.349 0.014 0.4 0.2–0.8
Groupf 1.513 0.407 0.001 4.5 2.0–10.1
B12g 0.714 0.338 0.034 2.0 1.1–4.0
Anemiag 0.535 0.262 0.041 1.7 1.02–2.9
Folateg 1.323 0.714 0.064 3.8 0.9–15.2
a: 64–70 yrs b: 71–79 c: ≥  80 d: Health Centre e: Open Centre for Elderly f: Old Peoples Home g: Abnormal valueBMC Family Practice 2001, 2:5 http://www.biomedcentral.com/1471-2296/2/5
sessed on the basis of the results of this cross-sectional
study. Why this association exists needs further discus-
sion. The impact which the changes on olfactory function
and taste associated with AD may have on dietary intake,
nutritional status and the haematinic factors is not ex-
amined in this study. The possible contribution of the
concomitant diseases on the causation of anemia should
not be ignored, when the results are interpreted. The
present study is based on people who have visited the
Health Centre and other older people who live at the
community setting. This situation reflects the current
figure of the real context in which the GPs are invited to
work. Anemia was also based on the HCT findings, but
both HCT and the blood Hb concentration remain the
best available indirect indicators [23,24]. The validity
and reliability of the used laboratory methods is an im-
portant issue as it can affect the study results. However
the lab of the HCCh was using quality controls and all the
blood tests were administered by the same assistant. The
use of MMSE as a screening tool has also been discussed
widely in the literature [25,26]. Even the MMSE's specif-
icity and sensitivity can be affected by factors such as sex,
education level, age [27] this tool remains to be a simple
screening tool at GP's disposal for cognitive impairment
and cannot be used to make even tentative psychiatric di-
agnoses [26,27].
Despite these limitations, our study adds to the existing
literature. This study also reveals that people, who are
living in Old People's Homes, were recognized at a spe-
cific risk and it is also in accordance with other reports
[28,29]. The greater risk of male subjects having cogni-
tive impairment when they are anemic in comparison
with females has been reported in another study [9].
This Greek study may have some serious implications on
the GPs attitude and practices when they identify elderly
cognitive impaired subjects; specifically, they could rec-
ommend them a hematological investigation including
HCT, CBC, Vit.B12 and folic acid levels. The initiation of
a adequate treatment with Vit.B12 and/or folate when
laboratory indications exist, seems to be an effective
strategy in General Practice and this treatment is recom-
mended, even in cases with a normal score with MMSE.
Some authorities recommend that serum B12 screening
should be initially performed to all elderly patients, with
further testing in those with a Vit.B12 level of less than
350 pg/ mL (260 pmol / L) [20]. Seeking the effective-
ness of different screening strategies, clinicians need to
use their own judgment to decide how to identify Vit.B12
deficiency before it leads to anemia or neurologic dis-
ease.
Conclusions
Anemia seems to be a risk factor for cognitive impair-
ment. There are also many questions whether Vit.B12
and folate deficiency work as risk factors on the onset of
dementia and whether the appearance of dementia can
be avoided by a supplemented treatment. Until definitive
clarifying of those questions GPs should be warranted to
screening, assaying, and treating elderly people.
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